ReviewMedComm2025

Toll-Like Receptors in the Immunotherapy Era: Dual-Edged Swords of Tumor Immunity and Clinical Translation.

Nueraili Maihemuti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.